Chong, Ming Chuen
Sharp, Melissa K.
Smith, Susan M.
O’Neill, Michelle
Ryan, Máirín
Lynch, Rosarie
Mahtani, Kamal R.
Clyne, Barbara
Funding for this research was provided by:
RCSI University of Medicine and Health Sciences (Research Summer School)
Health Research Board (EIA-2019-09, EIA-2019-09)
Article History
Received: 3 January 2023
Accepted: 18 March 2023
First Online: 25 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: BC, MON, MR, SMS are members of HRB-CICER, who independently review evidence and provide scientific support for the development, by guideline development groups, of the National Clinical Guidelines in Ireland. They have provided support for some of the guidelines included in this analysis. RL is Head of Clinical Effectiveness and Antimicrobial Resistance, Department of Health. MCC, MKS, KRM have no competing interests.